July, 2008
Calistoga Pharmaceuticals initiates First Oncology Clinical Trial of Novel Oral PI3K Delta Compound,
CAL-101...read more>

March, 2008
Calistoga Pharmaceuticals initiates its First Clinical Study of Novel Oral PI3K Delta Compound,
CAL-101...read more>

February, 2008
Reuters – New target promises better asthma and allergy drugs...read more>

January, 2008
Calistoga Pharmaceuticals announces completion of its Series A Financing - Investors increased funding by 25% to total $26.2 Million...read more >
 
March, 2007
Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of $21 million Series A Financing...read more>